AMGN vs. MRK: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and MRK, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With AMGN at 145.90 billion USD and MRK at 193.30 billion USD, their market capitalizations sit in the same ballpark.
With betas of 0.50 for AMGN and 0.44 for MRK, both show similar volatility profiles relative to the overall market.
| Symbol | AMGN | MRK |
|---|---|---|
| Company Name | Amgen Inc. | Merck & Co., Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Robert A. Bradway | Mr. Robert M. Davis J.D. |
| Price | 271.34 USD | 76.98 USD |
| Market Cap | 145.90 billion USD | 193.30 billion USD |
| Beta | 0.50 | 0.44 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 17, 1983 | January 13, 1978 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and MRK over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and MRK, please refer to the table below.
| Symbol | AMGN | MRK |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 11.18 |
| Forward PEG Ratio (TTM) | 7.08 | 4.93 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 3.02 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 4.03 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 11.34 |
| EV-to-EBITDA (TTM) | 15.71 | 8.04 |
| EV-to-Sales (TTM) | 5.70 | 3.43 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 12.88 |
Dividend Comparison
Both AMGN and MRK offer similar dividend yields (3.41% vs. 4.10%), indicating comparable approaches to balancing income and growth.
| Symbol | AMGN | MRK |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 4.10% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and MRK, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AMGN is heavily leveraged (debt-to-equity ratio 9.24), which can boost returns but raises risk if borrowing costs climb, while MRK at 0.72 keeps leverage at a more moderate level.
- AMGN meets its interest obligations (ratio 3.19). In stark contrast, MRK’s negative ratio (-75.48) means its operating earnings (EBIT) don't cover basic operations, let alone interest, signaling serious financial trouble.
| Symbol | AMGN | MRK |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 1.41 |
| Quick Ratio (TTM) | 0.88 | 1.16 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 0.72 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.30 |
| Interest Coverage Ratio (TTM) | 3.19 | -75.48 |